Showing results (361-370 of 757) with videos related to
Sort By:
Pageof 76
Kidney International|February 12, 2015
Protein carbamylation is associated with heart failure and mortality in diabetic patients with end-stage renal diseaseChristiane Drechsler, Sahir Kalim, Julia B Wenger, et al.Journal of Medical Genetics|June 12, 2020
Treatment switch in Fabry disease- a matter of dose?Malte Lenders, Peter Nordbeck, Sima Canaan-Kühl, et al.Heart (British Cardiac Society)|October 23, 2010
The right ventricle in Fabry disease: natural history and impact of enzyme replacement therapyMarkus Niemann, Frank Breunig, Meinrad Beer, et al.Plos One|April 21, 2015
Hepcidin-25 in diabetic chronic kidney disease is predictive for mortality and progression to end stage renal diseaseMartin Wagner, Damien R Ashby, Caroline Kurtz, et al.Clinical Pharmacology and Therapeutics|December 4, 2018
Oral Chaperone Therapy Migalastat for Treating Fabry Disease: Enzymatic Response and Serum Biomarker Changes After 1 YearJonas Müntze, Daniel Gensler, Octavian Maniuc, et al.Orphanet Journal of Rare Diseases|August 17, 2018
Characterization of vertigo and hearing loss in patients with Fabry diseaseMaria Köping, Wafaa Shehata-Dieler, Dieter Schneider, et al.Journal of Diabetes and Its Complications|August 26, 2023
Changes in cardiac and vascular haemodynamics as potential mediators of improvements in cardiovascular and kidney outcomes with empagliflozin in type 2 diabetesBernhard K Krämer, Sibylle J Hauske, Robert Chilton, et al.Kidney International. Supplement|April 16, 2003
Deficiencies of calcium-regulatory proteins in dialysis patients: a novel concept of cardiovascular calcification in uremiaMarkus Ketteler, Christoph Wanner, Thomas Metzger, et al.Environmental Science & Technology|January 8, 2020
Microbial U Isotope Fractionation Depends on the U(VI) Reduction RateAnirban Basu, Christoph Wanner, Thomas M Johnson, et al.International Journal of Oncology|December 28, 2011
Microtubule associated tumor suppressor 1 deficient mice develop spontaneous heart hypertrophy and SLE-like lymphoproliferative diseaseChristina Zuern, Laszlo Krenacs, Stephanie Starke, et al.Pageof 76